Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 125 Total
AMPE - Ampio Pharmaceuticals Inc - Stock Price Chart
CompanyAmpio Pharmaceuticals Inc
Market Cap1.58MEPS (ttm)-12.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.16%
P/S-EPS next 5Y-
P/B0.28EPS Q/Q82.04%
Dividend-Sales Q/Q-
Insider Own9.68%Inst Own0.33%
Insider Trans139.93%Inst Trans-41.50%
Short Float2.06%Earnings-
Analyst Recom1.00Target Price600.00
Avg Volume32.41K52W Range2.08 - 8.99
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BUCHI J KEVINDirectorJun 09Buy0.2921,8586,284146,858Jun 13 12:07 PM
BUCHI J KEVINDirectorJun 08Buy0.3025,0007,400125,000Jun 09 02:26 PM
MARTINO MICHAEL ACEOMay 24Buy0.2976,89022,12176,890May 26 01:30 PM
BUCHI J KEVINDirectorMay 16Buy0.2732,5348,924100,000May 17 04:25 PM
BUCHI J KEVINDirectorMay 15Buy0.2544,02610,85767,466May 16 03:30 PM
SGE - Strong Global Entertainment Inc - Stock Price Chart
TickerSGE [AMEX]
CompanyStrong Global Entertainment Inc
IndustryComputer Hardware
Market Cap9.38MEPS (ttm)0.10
P/E11.70EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.19EPS next 5Y-
P/B1.01EPS Q/Q-96.09%
Dividend-Sales Q/Q10.27%
Insider Own79.34%Inst Own0.21%
Insider Trans0.00%Inst Trans-
Short Float0.37%EarningsNov 09/a
Analyst Recom-Target Price-
Avg Volume6.98K52W Range1.30 - 4.35
Strong Global Entertainment, Inc. manufactures and distributes large format project screen & coatings. It also distribute digital cinema equipment and provide technical support services to the entertainment industry. Its key markets include the cinema exhibition industry, theme parks, schools, museums, networks and other entertainment-related markets. The company was founded on November 9, 2021 and is headquartered in Charlotte, North Carolina.
CRGE - Charge Enterprises Inc - Stock Price Chart
CompanyCharge Enterprises Inc
IndustryTelecom Services
Market Cap34.11MEPS (ttm)-0.20
P/E-EPS this Y47.14%
Forward P/E-EPS next Y37.84%
PEG-EPS past 5Y-133.34%
P/S0.05EPS next 5Y-
P/B1.41EPS Q/Q-191.89%
Dividend-Sales Q/Q-28.83%
Insider Own46.35%Inst Own16.88%
Insider Trans0.24%Inst Trans-2.72%
Short Float3.47%EarningsNov 08/b
Analyst Recom2.00Target Price4.50
Avg Volume598.97K52W Range0.17 - 2.29
Charge Enterprises, Inc. engages in the provision of electrical, broadbrand, and electric vehicle charging services. It offers end-to-end project management services, from advising, designing, engineering, acquiring and installing equipment, to monitoring, servicing, and maintenance. It operates through the Infrastructure and Telecommunications segments. The Infrastructure segment focuses on electric vehicle charging and broadband services. The Telecommunications segment deals with the connection of voice calls and data to global carriers. The company was founded by Andrew Fox on May 8, 2003 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Biehl JamesCLO, CCO, SecretarySep 14Buy0.6810,0006,80030,000Sep 18 07:16 AM
JACOBS GARY NDirectorSep 14Buy0.623,0001,86030,000Sep 18 07:17 AM
JACOBS GARY NDirectorSep 11Buy0.565,0002,80027,000Sep 12 09:03 AM
Deutsch JustinDirectorSep 08Buy0.46105,40048,4841,080,168Sep 11 07:17 AM
Scala PhilipDirectorSep 08Buy0.4844,00021,1201,125,887Sep 12 12:08 PM
NMRD - Nemaura Medical Inc - Stock Price Chart
CompanyNemaura Medical Inc
IndustryMedical Devices
Market Cap6.76MEPS (ttm)-0.38
P/E-EPS this Y22.81%
Forward P/E-EPS next Y2.27%
PEG-EPS past 5Y-41.56%
P/S-EPS next 5Y-
P/B-EPS Q/Q74.00%
Dividend-Sales Q/Q-100.00%
Insider Own48.27%Inst Own7.75%
Insider Trans0.00%Inst Trans-1.37%
Short Float1.29%EarningsAug 14/b
Analyst Recom1.00Target Price8.50
Avg Volume167.26K52W Range0.23 - 3.43
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
VLCN - Volcon Inc - Stock Price Chart
CompanyVolcon Inc
IndustryAuto Manufacturers
Market Cap0.96MEPS (ttm)-9.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.33EPS next 5Y-
P/B-EPS Q/Q-13.30%
Dividend-Sales Q/Q100.83%
Insider Own21.30%Inst Own4.37%
Insider Trans0.00%Inst Trans218.98%
Short Float4.36%EarningsOct 31/b
Analyst Recom1.00Target Price15.00
Avg Volume419.96K52W Range0.16 - 10.00
Volcon, Inc. engages in the design and development of electric outdoor power sports vehicles. It also offers electric two and four-wheel motorcycles and utility terrain vehicles. The company was founded by Christian Gerard Okonsky and Adrian James on February 21, 2020 and is headquartered in Round Rock, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Endo GregChief Financial OfficerFeb 13Option Exercise1.0025,00025,00033,563Feb 15 07:39 AM
OCEA - Ocean Biomedical Inc. - Stock Price Chart
CompanyOcean Biomedical Inc.
Market Cap32.65MEPS (ttm)-3.25
P/E-EPS this Y-498.06%
Forward P/E-EPS next Y71.10%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-3415.71%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own18.36%
Insider Trans0.00%Inst Trans2.79%
Short Float6.04%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume226.57K52W Range1.01 - 26.60
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
Nov-01-23 07:00AM Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now (GlobeNewswire)
Oct-31-23 07:00AM Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now (GlobeNewswire)
Oct-26-23 06:30AM EXCLUSIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B (Benzinga)
05:30AM Virion Therapeutics and Joint Venture Partner, Ocean Biomedical (NASDAQ: OCEA), Announce First Patients Dosed with Novel Immunotherapy Evaluating a Functional Cure for Chronic Hepatitis B Virus Infection (PR Newswire)
05:30AM Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection (GlobeNewswire)
Oct-24-23 06:30AM Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis (GlobeNewswire)
Oct-17-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Enrollment of Patients for Phase 1b Study for Chronic Hepatitis B Treatment in 50-50 Joint Venture with Virion Therapeutics (GlobeNewswire)
Oct-12-23 08:01AM Virion Therapeutics and Ocean Biomedical form joint venture supporting multi-national, first-in-humans clinical chronic hepatitis B study: now enrolling, with goal of a functional cure for a disease affecting 300+ million patients worldwide (PR Newswire)
08:01AM Ocean Biomedical and Virion Therapeutics Form Joint Venture Supporting Multi-National, First-In-Humans Clinical Chronic Hepatitis B Study: Now Enrolling, With Goal of a Functional Cure for a Disease Affecting 300+ Million Patients Worldwide (GlobeNewswire)
Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.
VMAR - Vision Marine Technologies Inc - Stock Price Chart
CompanyVision Marine Technologies Inc
IndustryRecreational Vehicles
Market Cap19.88MEPS (ttm)-1.71
P/E-EPS this Y7.02%
Forward P/E-EPS next Y41.75%
PEG-EPS past 5Y-146.70%
P/S4.73EPS next 5Y-
P/B2.25EPS Q/Q17.51%
Dividend-Sales Q/Q-39.27%
Insider Own61.35%Inst Own4.86%
Insider Trans0.00%Inst Trans1.30%
Short Float2.06%EarningsJul 14/a
Analyst Recom1.00Target Price5.22
Avg Volume39.12K52W Range1.75 - 5.65
Vision Marine Technologies, Inc. engages in the design, development, and manufacturing of electric outboard powertrain systems and electric boats. It operates through the Sale of Electric Boats and Rental of Electric Boats segments. The Sale of Electric Boats segment involves in the manufacture of customized electric boats for the consumer market and the sale of boat parts and maintenance. The Rental of electric boats segment includes short-term rental operations and boat club membership. The company was founded in 1995 and is headquartered in Boisbriand, Canada.
STKH - Steakholder Foods Ltd ADR - Stock Price Chart
CompanySteakholder Foods Ltd ADR
IndustryPackaged Foods
Market Cap9.40MEPS (ttm)-2.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-20.14%
P/S-EPS next 5Y-
P/B13.50EPS Q/Q-362.55%
Dividend-Sales Q/Q-100.00%
Insider Own-Inst Own3.37%
Insider Trans-Inst Trans-4.57%
Short Float0.05%EarningsAug 30/a
Analyst Recom1.00Target Price3.80
Avg Volume94.49K52W Range0.55 - 2.24
Steakholder Foods Ltd. operates as a deep-technology food company, which uses science and technology to provide real meat products. It focuses on the development of novel, proprietary three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. The company was founded by Arik Kaufman, Yaron Kaiser, Sharon Fima, and Omri Schanin on July 22, 1992 and is headquartered in Rehovot, Israel.
CHPT - ChargePoint Holdings Inc - Stock Price Chart
CompanyChargePoint Holdings Inc
IndustrySpecialty Retail
Market Cap694.90MEPS (ttm)-1.06
P/E-EPS this Y-54.94%
Forward P/E-EPS next Y43.45%
PEG-EPS past 5Y-140.39%
P/S1.27EPS next 5Y-
P/B2.52EPS Q/Q-
Dividend-Sales Q/Q-9.85%
Insider Own21.47%Inst Own38.98%
Insider Trans-5.98%Inst Trans-0.48%
Short Float22.19%EarningsDec 06/a
Analyst Recom2.30Target Price5.81
Avg Volume18.04M52W Range1.93 - 13.65
TodayDowngrade UBS Buy → Neutral $9 → $2.25
ChargePoint Holdings, Inc. operates as an electric vehicle charging network provider. It designs, develops and markets networked electric vehicle charging system infrastructure and its Cloud Services enable consumers the ability to locate, reserve, authenticate and transact electric vehicle charging sessions. The firm provides an open platform providing real-time information about charging sessions and control, support and management of the networked charging systems. This network provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. The company was founded in 2007 and is headquartered in Campbell, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gerdes HenrikChief Accounting OfficerOct 18Option Exercise0.7643,59633,133121,806Oct 20 04:57 PM
JACKSON REX SChief Financial OfficerSep 21Sale5.0316,79984,5331,973,546Sep 25 08:40 PM
Hughes Michael DSee RemarksSep 21Sale5.0313,72969,079869,942Sep 25 08:39 PM
Wilmer RichardSee RemarksSep 21Sale5.038,19141,218628,840Sep 25 08:41 PM
Gerdes HenrikChief Accounting OfficerSep 21Sale5.035,32826,81478,210Sep 25 08:36 PM
TCBP - TC Biopharm (Holdings) Plc - Stock Price Chart
CompanyTC Biopharm (Holdings) Plc
CountryUnited Kingdom
Market Cap3.23MEPS (ttm)-17.21
P/E-EPS this Y97.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.90EPS next 5Y-
P/B0.05EPS Q/Q100.80%
Dividend-Sales Q/Q-
Insider Own11.74%Inst Own12.40%
Insider Trans0.00%Inst Trans0.10%
Short Float11.77%Earnings-
Analyst Recom2.00Target Price7.00
Avg Volume346.24K52W Range0.36 - 96.10
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Randall Diana Elizabeth10% OwnerNov 30Buy5.0070,000350,00070,000Jan 11 04:29 PM
Randall Kenneth Edward10% OwnerNov 30Buy5.0070,000350,000382,963Jan 11 03:07 PM
Randall Mark Edward10% OwnerNov 30Buy5.0070,000350,000382,963Jan 11 03:30 PM
Renaissance Capital Partners L10% OwnerNov 30Buy5.0070,000350,000136,834Jan 11 02:17 PM